|
⚲
|
| Keyboard |
| Ogden Cap Associates LLC
✚
|
|
|---|---|
| CIK # | 0001885867 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001885867] | |
| 4 | [0001885867] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cognition Therapeutics Inc | |
| Ogden Cap Associates LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 407,916 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 103,055 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 272,756 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 1,263,575 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Option exercise | 27,471 | $0.03 | 824 |
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Conversion | 135,679 | ||
|
Cognition Therapeutics Inc CGTX
Common Stock
|
2021-10-13 | Sell | 74.05 | $12.00 | 889 |
|
Cognition Therapeutics Inc CGTX
Warrant (right to buy) · derivative
|
2021-10-13 | Option exercise | 27,471 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series B-1 Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 438,854 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series B Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 4,087,046 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series A-1 Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 333,333 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series A Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 1,319,408 | $0.00 | |
|
Cognition Therapeutics Inc CGTX
Series A-2 Convertible Preferred Stock · derivative
|
2021-10-13 | Conversion | 882,233 | $0.00 |